Single-intraosseous simvastatin injection suppresses cancers via activating CD8+ T cells
Wanqiong Yuan(Beijing Haidian Hospital), Chunli Song(Peking University), Chenggui Zhang(Yunnan Agricultural University), Wang Zhang(Seoul National University), Hong Wang(Zhejiang University of Technology), Jie Huang(Menlo School), Junxiong Zhu(Peking University), Zhiyuan Guan(Tongji University), Xiaoqing Ren(Peking University), Huijie Leng(Peking University)
Cited by 27
Related Papers
First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced Cancers
|Journal of Clinical Oncology|2019|590
Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus
|Arthritis & Rheumatism|2010|481
Microbial metabolite enhances immunotherapy efficacy by modulating T cell stemness in pan-cancer
|Cell|2024|372
Fatty acid oxidation fuels glioblastoma radioresistance with CD47-mediated immune evasion
|Nature Communications|2022|243
CPT1A/2-Mediated FAO Enhancement—A Metabolic Target in Radioresistant Breast Cancer
|Frontiers in Oncology|2019|169